CEMP Overview
Upcoming Projects (CEMP)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (CEMP)
-
Don’t see a project related to the company you care about? Create your own!
Upcoming & Overdue Catalysts (CEMP)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (CEMP)
-
Cempra (CEMP) Phase 3 Results Evaluating CEM-102 in Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
Ticker: CEMP
Occurred on: Feb 24, 2017 -
PDUFA Date for Solithera (solithromycin) Oral Capsules in Community-Acquired Bacterial Pneumonia (CABP) Set for December 27
Ticker: CEMP
Occurred on: Dec 29, 2016 -
PDUFA Date for Intravenous Solithera (solithromycin) in Community-Acquired Bacterial Pneumonia (CABP) Set for December 28
Ticker: CEMP
Occurred on: Dec 29, 2016 -
Cempra to Present Solithromycin at FDA Antimicrobial Drugs Advisory Committee Meeting on November 4, 2016
Ticker: CEMP
Occurred on: Nov 07, 2016 -
Cempra's Pivotal Phase 3 SOLITAIRE-IV Study of IV to Oral Solithromycin Published in Clinical Infectious Diseases
Ticker: CEMP
Occurred on: Aug 25, 2016 -
Cempra Announces European Medicines Agency Validates MAA for Solithromycin for Treatment of CABP
Ticker: CEMP
Occurred on: Aug 23, 2016 -
Cempra Announces FDA Acceptance of Solithera New Drug Applications in the Treatment of Community-Acquired Bacterial Pneumonia
Ticker: CEMP
Occurred on: Jul 05, 2016 -
Cempra Authorized to Receive Funds From BARDA for a Phase 2/3 Clinical Trial of Solithromycin in Pediatric Patients
Ticker: CEMP
Occurred on: Mar 07, 2016
Strategic Initiatives (CEMP)
-
Don’t see a strategic initiative related to the company you care about? Create your own!